Finance Doctor Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.70 M
as on 12-12-2024
- Revenue 13.82%
(FY 2023)
- Profit -93.19%
(FY 2023)
- Ebitda 1.13%
(FY 2023)
- Net Worth 4.28%
(FY 2023)
- Total Assets -8.89%
(FY 2023)
About Finance Doctor
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjiv Mehta, Sarswati Mehta, Sahir Mehta, and One other member serve as directors at the Company.
- CIN/LLPIN
U65999TG2002PTC039645
- Company No.
039645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2002
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Finance Doctor Private Limited offer?
Finance Doctor Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Finance Doctor?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Mehta  | Managing Director | 19-Sep-2002 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarini Mehta | Director | 08-Jan-2018 | Current |
| Sarswati Mehta | Director | 19-Sep-2002 | Current |
| Sahir Mehta | Director | 02-Nov-2015 | Current |
Financial Performance of Finance Doctor.
Finance Doctor Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.82% increase. The company also saw a substantial fall in profitability, with a 93.19% decrease in profit. The company's net worth moved up by a moderate rise of 4.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finance Doctor?
In 2023, Finance Doctor had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Little Big Stories Private LimitedActive 6 years 11 monthsSanjiv Mehta and Sahir Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Nov 2015 | ₹2.70 M | Satisfied |
How Many Employees Work at Finance Doctor?
Unlock and access historical data on people associated with Finance Doctor, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Finance Doctor, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finance Doctor's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
